Denmark· DK-28100903176
Ludiomil
A maprotiline product containing maprotilinhydrochlorid, registered in Denmark by Amdipharm Limited. The same ATC class is registered in 8 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Maprotiline is registered in 8 of 19 countries.
Countries holding a registration under ATC N06AA21 (maprotiline), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 4 of them publish a price we can compare per daily dose
Maprotiline · ATC N06AA21
8 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Japan
- Polandprice
- United Kingdom
Price per daily dose
What a daily dose of maprotiline costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Maprotiline · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- FR France$0.40
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- MAPROTILINHYDROCHLORID
- Manufacturer
- Amdipharm Limited
- Country
- Denmark (DK)
- ATC code
- N06AA21
- ATC class
- Maprotiline
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28100903176
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
335 interactions on record for maprotiline.
Graded by severity as the source publishes them — 55 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Maprotiline · interactions on record
335 records
- 55 severe
- 204 moderate
- 8 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
68 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N06AA21
Maprotiline, as other registers publish it.
- FinlandLudiomilNovartis Pharma AG
- FinlandLudiomilNovartis Pharma AG
- PolandLudiomilAmdipharm Limited
- United KingdomLudiomil 10mg tabletsNovartis Pharmaceuticals UK Ltd
- BelgiumLudiomil 25 mgAmdipharm
- FranceLUDIOMIL 25 mg, comprimé pelliculéAMDIPHARM
- United KingdomLudiomil 25mg tabletsNovartis Pharmaceuticals UK Ltd
- BelgiumLudiomil 50 mgAmdipharm
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e1878f11-4418-4785-aa46-68ecc2d483c8 GET /v1/drugs/e1878f11-4418-4785-aa46-68ecc2d483c8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "75 mg",
"auth_role": "DKMA",
"dk_drugid": "28100903176",
"substance": "MAPROTILINHYDROCHLORID",
"auth_procedure": "National",
"in_medicinpriser": false,
"registration_date_serial": "28305"
}See everything about maprotiline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.